Objective: This paper reviews the pharmacology, clinical efficacy, and tolerability of
pantoprazole in comparison with those of other available proton pump inhibitors (PPIs) …

Prophylaxis is routinely provided for critically ill patients admitted to intensive care units
(ICUs) who are at high risk for stress-related mucosal damage (SRMD), an erosive process …

The terrible rise of antibiotic residues which possesses a serious threat to the ecological and
aquatic environments. So, the development of highly cost-effective, highly operation …

Background: Proton pump inhibitors have emerged as the most effective class of drugs for
the treatment of gastro‐oesophageal reflux. Pantoprazole is a proton pump inhibitor that has …

Background: Short-term use of standard-dose proton pump inhibitors (PPIs) is the first-line
initial non-eradication treatment for duodenal ulcer (DU), but the choice on individual PPI …

AIM: To assess the risk factors and the efficacy of medications of patients with gastric and
duodenal ulcers among Chinese patients in Taiwan. METHODS: Patients with peptic ulcers …

Accepted: Feb 24, 2014; Published: Mar 12, 2014 Abstract: This research aimed to
determine the potential protective effects ofPhaleria macrocarpafruit extracton rat gastric …

The present network meta‑analysis aimed to enhance the corresponding evidence with
respect to the efficacy and safety of pharmaceuticals treatments. Frequentist network meta …

2. Lai R, Medeiros LJ. Pathological diagnosis of mantle cell lymphoma. Clin Lymphoma
2000; 1: 207–8. 3. Foss HD, Stein H. Pathology of intestinal lymphomas. Recent Results …

Proton pump inhibitors decrease secretion of gastric acid. They act by blocking the last
enzyme in the system that actively transports acid from gastric parietal cells into the …